November 23, 2016 - By Dolores Ford · 0 Comments
Nov 23 is a positive day so far for PowerShares Dynamic Biotech & Genome ETF (NYSEARCA:PBE) as the ETF is active during the day after gaining 0.45% to hit $42.5 per share. The exchange traded fund has 247.21M net assets and 2.30% volatility this month.
Over the course of the day 4,465 shares traded hands, as compared to an average volume of 28,880 over the last 30 days for PowerShares Dynamic Biotech & Genome ETF (NYSEARCA:PBE).
The ETF is -16.63% of its 52-Week High and 26.72% of its low, and is currently having ATR of 1.14. This year’s performance is -14.67% while this quarter’s performance is 2.15%.
The ETF’s YTD performance is -25.98%, the 1 year is -24.77% and the 3 year is 2.64%.
The ETF’s average P/E ratio is 21.75, the price to book is 2.98, the price to sales is 5.2 and the price to cashflow is 9.45. It was started on 6/23/2005. The fund’s top holdings are: Incyte Corporation for 6.11% of assets, Alexion Pharmaceuticals Inc. for 5.69%, Gilead Sciences Inc. for 5.17%, Biogen Inc. for 5.14%, Regeneron Pharmaceuticals Inc. for 4.85%, BioMarin Pharmaceutical Inc. for 4.77%, Amgen Inc. for 4.67%, Vertex Pharmaceuticals Incorpor for 4.43%, Corcept Therapeutics Incorporat for 3.91%, Seattle Genetics Inc. for 3.61%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as 0.91% yield.
More notable recent PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE) news were published by: Investorplace.com which released: “3 Biotech ETFs for Decades of Big Returns” on November 15, 2016, also Etftrends.com with their article: “You’re Missing out on a Super Software ETF” published on April 24, 2015, Zacks.com published: “Biotech ETF Industry Outlook” on August 31, 2016. More interesting news about PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE) were released by: Etftrends.com and their article: “Biotech Hedge Funds are hot, but Biotech ETFs are Hotter” published on May 29, 2015 as well as Etftrends.com‘s news article titled: “‘Tis the Season for Biotech ETFs” with publication date: January 05, 2015.
PowerShares Dynamic Biotechnology & Genome Portfolio is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The ETF has a market cap of $247.21 million. The Fund seeks investment results that correspond generally to the price and yield of the Index. It has a 3.27 P/E ratio. The Index consists of stocks of 30 the United States biotechnology and genome companies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford